BUZZ-U.S. STOCKS ON THE MOVE-Ligand, EndoChoice, CEL-SCI, Chesapeake Energy
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) Wall Street rose for the first time in three days on Tuesday, helped by technology and discretionary stocks.
The Dow Jones Industrial Average was up 0.72 percent at 18,226.01, the S&P 500 was up 0.63 percent at 2,159.59 and the Nasdaq Composite was up 0.87 percent at 5,303.283.
** AMGEN INC, $171.25, -1.31 pct
** LIGAND PHARMACEUTICALS INC, $99.87, -11.69 pct
Amgen said its multiple myeloma drug, Kyprolis, did not surpass Takeda Pharmaceutical Co Ltd's Velcade in a head-to-head late-stage study in previously untreated patients.
Ligand gets royalties on Kyprolis sales.
** AMAZON.COM INC, $815.76, +2.08 pct
JP Morgan raised its target price on the online retailer's stock to $1000 from $925. Continued...